Laboratory Medicine ›› 2017, Vol. 32 ›› Issue (2): 158-160.DOI: 10.3969/j.issn.1673-8640.2017.02.020
• Orginal Article • Previous Articles
Received:2016-03-14
Online:2017-03-30
Published:2017-03-30
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2017.02.020
| 批号 | 靶值（g/L） | 允许范围（g/L） | 均值（g/L） | 相对偏移（%） |
|---|---|---|---|---|
| 201431 | 45.5 | 41.0~50.0 | 47.65 | 4.70 |
| 201432 | 34.7 | 31.2~38.2 | 35.46 | 2.20 |
| 201433 | 50.4 | 45.4~55.4 | 52.68 | 4.50 |
| 201434 | 37.9 | 34.1~41.7 | 39.37 | 3.90 |
| 201435 | 28.5 | 25.6~31.7 | 29.54 | 3.60 |
| 批号 | 靶值（g/L） | 允许范围（g/L） | 均值（g/L） | 相对偏移（%） |
|---|---|---|---|---|
| 201431 | 45.5 | 41.0~50.0 | 47.65 | 4.70 |
| 201432 | 34.7 | 31.2~38.2 | 35.46 | 2.20 |
| 201433 | 50.4 | 45.4~55.4 | 52.68 | 4.50 |
| 201434 | 37.9 | 34.1~41.7 | 39.37 | 3.90 |
| 201435 | 28.5 | 25.6~31.7 | 29.54 | 3.60 |
| 相对偏移来源 | 相对偏移（%） | σ值 | QGI | 优先改进 |
|---|---|---|---|---|
| EQA回报结果 | 1.55 | 2.90 | 0.36 | 精密度 |
| 室内质控数据 | 3.50 | 2.20 | 0.80 | 精密度 |
| EQA调查品 | 3.78 | 2.10 | 0.86 | 精密度和正确度 |
| 罗氏c.f.a.s校准品 | 3.80 | 2.10 | 0.87 | 精密度和正确度 |
| Alb标准品 | 9.60 | 0.34 | 17.60 | 正确度 |
| 相对偏移来源 | 相对偏移（%） | σ值 | QGI | 优先改进 |
|---|---|---|---|---|
| EQA回报结果 | 1.55 | 2.90 | 0.36 | 精密度 |
| 室内质控数据 | 3.50 | 2.20 | 0.80 | 精密度 |
| EQA调查品 | 3.78 | 2.10 | 0.86 | 精密度和正确度 |
| 罗氏c.f.a.s校准品 | 3.80 | 2.10 | 0.87 | 精密度和正确度 |
| Alb标准品 | 9.60 | 0.34 | 17.60 | 正确度 |
| [1] | .WESTGARD J O,WESTGARD S A.The quality of laboratory testing today:an assessment of sigma metrics for analytic quality using performance data from proficiency testing surveys and the CLIA criteria for acceptable performance[J]. Am J Clin Pathol,2006,125(3):343-354. |
| [2] | .SINGH B,GOSWAMI B,GUPTA V K,et al.Application of sigma metrics for the assessment of quality assurance in clinical biochemistry laboratory in India:a pilot study[J]. Indian J Clin Biochem,2011,26(2):131-135. |
| [3] | .王治国. 临床检验方法确认与性能验证[M]. 北京:人民卫生出版社,2009:160-166. |
| [4] | .王建兵,郑松柏,徐建华,等. 三种临床化学检测项目测量结果准确度验证方法的比较[J]. 中国现代医学杂志,2009,19(9):1384-1387. |
| [5] | .袁海生,杨立顺,张好为. 应用Westgard方法性能决定图及6σ质量标准评价仪器性能[J]. 国际检验医学杂志,2011,32(16):1877-1879. |
| [6] | .张秀明,温冬梅,王伟佳,等. 电化学发光免疫法检测NT-proBNP的分析性能评价[J]. 中华检验医学杂志,2011,34(12):1152-1157. |
| [7] | .李园园,李萍,宋昊岚,等. 应用6σ理论评价临床实验室各阶段性能及设计质控方案[J]. 中华检验医学杂志,2007,30(12):1408-1412. |
| [8] | .COSKUN A.Six sigma and calculated laboratory tests[J]. Clin Chem,2006,52(4):770-771. |
| [9] | .王建斌,周敬敬,郑松柏,等. 两种允许总误差在临床化学检测项目性能评价中的应用[J]. 中国医疗设备,2009,24(7):61-63. |
| [10] | .何法霖,王薇,钟堃,等. 3种允许总误差(TEa)质量规范在血脂室间质评中的应用[J]. 临床检验杂志, 2012, 30(1):70-71. |
| [11] | .居漪,吕元. 能力验证提供者认可准则在检验医学领域中的应用策略探讨[J]. 检验医学,2015,30(11):1055-1058. |
| [12] | .王伦善,贾建安,金玉亮,等. 6σ标准在临床生化质量管理中的应用[J]. 临床输血与检验,2014,16(3):269-272. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
